Localization of a membrane glycoprotein in benign fibrocystic disease and infiltrating duct carcinomas of the human breast with the use of a monoclonal antibody to guinea pig milk fat globule membrane.
With monoclonal antibody D-274, raised against guinea pig milk fat globule membrane, the distribution of mucinlike glycoproteins of Mrs greater than or equal to 400,000 was determined in benign fibrocystic disease and infiltrating duct carcinoma of the human breast. These glycoproteins, called collectively PAS-I, were detected in 19 out of 20 cases of benign fibrocystic disease and in at least 26 out of 47 cases of infiltrating duct carcinoma. PAS-I was concentrated on luminal surfaces of ducts and alveoli in morphologically differentiated regions of the tumors. In areas where the glandular nature of the tissue was less evident in infiltrating duct carcinoma, the PAS-I determinant recognized by antibody D-274 was present on irregular luminal surfaces and in the cytoplasm. There was a negative correlation between the short-term recurrence (less than 2 years) of infiltrating duct carcinoma and the detection of strong positive staining with antibody D-274. The results are discussed with reference to recent studies on PAS-I in human breast tissue using monoclonal antibodies raised against human milk fat globule membrane.
Greenwalt
D E
DE
Johnson
V G
VG
Kuhajda
F P
FP
Eggleston
J C
JC
Mather
I H
IH
D000818:Animals; D000911:Antibodies, Monoclonal; D000918:Antibody Specificity; D001940:Breast / Q000032:analysis; D001943:Breast Neoplasms / Q000032:analysis*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000032:analysis*; D000939:Epitopes; D005260:Female; D005348:Fibrocystic Breast Disease / Q000378:metabolism*; D006168:Guinea Pigs / Q000276:immunology; D006801:Humans; D008565:Membrane Proteins / Q000032:analysis*; D018396:Mucin-1; D011379:Prognosis
D000911:Antibodies, Monoclonal; D000939:Epitopes; D008565:Membrane Proteins; D018396:Mucin-1